Sarasota-based Omeza, a skin health and tissue regeneration company, recently appointed Santino Costanzo its vice-president and chief commercial officer. Constanzo, who has more than 35 years of experience in medical sales leadership, will develop, direct and scale Omeza’s sales and marketing teams to meet strategic commercial objectives. In September, Omeza received 510(k) approval of its lead drug-device combination product, Omeza Collagen Matrix, as well as FDA clearance to go to market.